{"id":61045,"date":"2026-09-17T12:19:24","date_gmt":"2026-09-17T06:49:24","guid":{"rendered":"https:\/\/delhinewswatch.com\/index.php\/2026\/09\/17\/fredun-pharmaceuticals-ltd-acquires-furlicks-from-pharma-major-usv-its-subsidiary-wellbeing-nutrition\/"},"modified":"2026-09-17T12:19:24","modified_gmt":"2026-09-17T06:49:24","slug":"fredun-pharmaceuticals-ltd-acquires-furlicks-from-pharma-major-usv-its-subsidiary-wellbeing-nutrition","status":"publish","type":"post","link":"https:\/\/delhinewswatch.com\/index.php\/2026\/09\/17\/fredun-pharmaceuticals-ltd-acquires-furlicks-from-pharma-major-usv-its-subsidiary-wellbeing-nutrition\/","title":{"rendered":"Fredun Pharmaceuticals Ltd. Acquires Furlicks from Pharma Major USV &amp; its subsidiary Wellbeing Nutrition"},"content":{"rendered":"<div>\n<p class=\"wp-block-paragraph\"><strong>Mumbai (Maharashtra) [India], September 17:<\/strong> Fredun Pharmaceuticals Limited (FPL) has acquired <em><strong>Furlicks<\/strong><\/em>, an innovative pet-wellness brand focused on convenient, easy-to-administer oral-strip solutions for pets. The acquisition of <em><strong>Furlicks from USV &amp; Wellbeing Nutrition<\/strong><\/em> brings the brand\u2019s differentiated product innovation and consumer understanding into the FPL Group.<\/p>\n<p class=\"wp-block-paragraph\">This move further creates an opportunity to leverage FPL\u2019s established capabilities in <em><strong>manufacturing, product development, quality systems, R&amp;D, supply chain and distribution<\/strong><\/em> in the pet-care industry.<\/p>\n<p class=\"wp-block-paragraph\">With pet parenting evolving from a predominantly need-based approach towards a more proactive focus on <em><strong>preventive health<\/strong><\/em>, the acquisition comes at a time when pet parents are becoming more aware and increasingly willing to invest in <em><strong>nutrition and specialised products for their pets<\/strong><\/em>.<\/p>\n<p class=\"wp-block-paragraph\">Furlicks addresses this consumer need through its oral-strip format, offering an alternative to conventional\u00a0forms\u00a0of\u00a0pet\u00a0supplements.\u00a0Its\u00a0existing\u00a0portfolio\u00a0spans\u00a0key\u00a0pet-wellness\u00a0categories\u00a0including\u00a0<strong>skin and coat, gut health, joint care, calming, oral care and multivitamins<\/strong>, providing a strong foundation for further category expansion and product innovation.<\/p>\n<p class=\"wp-block-paragraph\">Speaking on the acquisition,\u00a0<strong>Mr. Fredun Medhora, MD &amp; CFO, Fredun Pharmaceuticals Ltd.\u00a0<\/strong>stated, \u201cFurlicks\u00a0marks\u00a0a\u00a0bold\u00a0new\u00a0chapter\u00a0in\u00a0FPL\u2019s\u00a0journey\u00a0into\u00a0pet\u00a0wellness.\u00a0We\u00a0see\u00a0Furlicks\u00a0as\u00a0more\u00a0than\u00a0an addition to our portfolio- it is a differentiated platform with the potential to build a significant<\/p>\n<p class=\"wp-block-paragraph\">pet-wellness business. By combining Furlicks\u2019 innovation and consumer-first approach with FPL\u2019s manufacturing capabilities, scale and execution strength, we aim to make quality pet care more accessible to millions of pet parents across India. Our focus is to scale Furlicks while preserving what makes\u00a0the\u00a0brand\u00a0special:\u00a0its\u00a0innovation,\u00a0simplicity\u00a0and\u00a0deep\u00a0understanding\u00a0of\u00a0pet\u00a0parents.\u00a0With\u00a0FPL\u2019s resources\u00a0and\u00a0capabilities\u00a0behind\u00a0it,\u00a0we\u00a0see\u00a0a\u00a0strong\u00a0opportunity\u00a0to\u00a0take\u00a0what\u00a0Furlicks\u00a0has\u00a0built\u00a0to\u00a0the next level and create India\u2019s first comprehensive pet-wellness platform.<strong>\u201d<\/strong><\/p>\n<p class=\"wp-block-paragraph\">The\u00a0immediate\u00a0focus\u00a0for\u00a0FPL\u00a0will\u00a0be\u00a0on\u00a0scaling\u00a0the\u00a0existing\u00a0business\u00a0by\u00a0introducing\u00a0<strong><em>12\u00a0new\u00a0SKUs\u00a0in\u00a0the 1st phase, with 32 new SKUs aligned for launch in the second phase<\/em><\/strong>. Over time, the ambition is to evolve Furlicks from a differentiated oral-strip proposition into a broader\u00a0<strong>everyday pet-wellness\u00a0platform<\/strong>.<\/p>\n<h3 class=\"wp-block-heading\">About\u00a0Fredun\u00a0Pharmaceuticals\u00a0Limited<\/h3>\n<p class=\"wp-block-paragraph\">Fredun Pharmaceuticals Limited (FPL) is a legacy brand in the healthcare segment with expertise spanning\u00a0four\u00a0decades,\u00a0with\u00a0a focus\u00a0on\u00a0pharmaceuticals,\u00a0healthcare,\u00a0consumer-facing\u00a0wellness\u00a0and specialised healthcare categories. Through its businesses and subsidiaries, FPL continues to build capabilities\u00a0across\u00a0product\u00a0development,\u00a0manufacturing,\u00a0distribution,\u00a0and\u00a0consumer-focused\u00a0healthcare\u00a0solutions.<\/p>\n<h3 class=\"wp-block-heading\">About\u00a0Furlicks<\/h3>\n<p class=\"wp-block-paragraph\">Furlicks is a pet-wellness brand focused on making everyday pet care simpler and more convenient through\u00a0innovative\u00a0oral-strip\u00a0solutions.\u00a0Its\u00a0portfolio\u00a0spans\u00a0categories\u00a0including\u00a0skin\u00a0and\u00a0coat,\u00a0gut\u00a0health, joint\u00a0care,\u00a0calming,\u00a0oral\u00a0care,\u00a0and\u00a0multivitamins,\u00a0with\u00a0a\u00a0focus\u00a0on\u00a0convenient\u00a0formats\u00a0designed\u00a0around\u00a0the needs of modern pet parents.<\/p>\n<p class=\"wp-block-paragraph\"><em>If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.<\/em><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Mumbai (Maharashtra) [India], September 17: Fredun Pharmaceuticals Limited (FPL) has acquired Furlicks, an innovative pet-wellness brand focused on convenient, easy-to-administer oral-strip solutions for pets. The acquisition of Furlicks from USV &amp; Wellbeing Nutrition brings the brand\u2019s differentiated product innovation and consumer understanding into the FPL Group. This move further creates an opportunity to leverage FPL\u2019s [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":61046,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[628],"class_list":["post-61045","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-business"],"_links":{"self":[{"href":"https:\/\/delhinewswatch.com\/index.php\/wp-json\/wp\/v2\/posts\/61045","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/delhinewswatch.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/delhinewswatch.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/delhinewswatch.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/delhinewswatch.com\/index.php\/wp-json\/wp\/v2\/comments?post=61045"}],"version-history":[{"count":0,"href":"https:\/\/delhinewswatch.com\/index.php\/wp-json\/wp\/v2\/posts\/61045\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/delhinewswatch.com\/index.php\/wp-json\/wp\/v2\/media\/61046"}],"wp:attachment":[{"href":"https:\/\/delhinewswatch.com\/index.php\/wp-json\/wp\/v2\/media?parent=61045"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/delhinewswatch.com\/index.php\/wp-json\/wp\/v2\/categories?post=61045"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/delhinewswatch.com\/index.php\/wp-json\/wp\/v2\/tags?post=61045"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}